Antiinflammatory and antifibrotic properties of colchicine: Implications for idiopathic pulmonary fibrosis

Lung

Volumn 175, Issue 1, 1997, Pages 41-51

  Entzian, P ^a   Schlaak, M ^a   Seitzer, U ^a   Bufe, A ^a   Acil, Y ^b   Zabel, P ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Colchicine; Collagen; Cytokines; Fibroblast growth; Idiopathic pulmonary fibrosis

Indexed keywords

COLCHICINE; COLLAGEN; INTERLEUKIN 1; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COLLAGEN SYNTHESIS; FIBROGENESIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; LUNG FIBROSIS; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031060544     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007555     Document Type: Article

References (39)

1. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416
2. Allen JN, Herzyk DJ, Wewers MD (1991) Colchicine has opposite effects on interleukin-1β and tumor necrosis factor-α production. Am J Physiol 261:L315-L321
3. Baughman RP, Lower EE (1992) Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest 102:1090-1094
4. Border WA, Noble NA (1994) Transforming growth factor β in tissue fibrosis. N Engl J Med 331: 1286-1292
5. Border WA, Ruoslahti E (1992) Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 90:1-7
6. Cherniack RM, Crystal RG, Kalica AR (1991) Current concepts in idiopathic pulmonary fibrosis: a road map for the future. Am Rev Respir Dis 143:680-683
7. Crouch E (1990) Pathobiology of pulmonary fibrosis. Am J Physiol 259:L159-L184
8. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277
9. Diegelmann RF,. Peterkofsky B (1972) Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc Natl Acad Sci USA 69:892-896
10. Dubrawsky C, Dubravsky NB, Withers HR (1978) The effect of colchicine on the accumulation of hydroxyproline and on lung compliance after irradiation. Radiat Res 73:111-120
11. Ehrlich HP, Ross R, Bornstein P (1974) Effect of antimicrotubular agent on the secretion of collagen: a biochemical and morphological study. J Cell Biol 62:390-405
12. Espevik T, Nissen-Meyer J (1986) A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105
13. Fabisiak JP, Kelley J (1992) Platelet-derived growth factor. In: Kelley J (ed) Cytokines of the Lung. Marcel Dekker, New York, pp 3-39
14. Ferrua B, Manie S, Doglio A, Shaw A, Sonthonnax S, Limouse M, Schaffar L (1990) Stimulation of human interleukin-1 production and specific mRNA expression by microtubule-disrupting drugs. Cell Immunol 131:391-397
15. Goddard CJR, Warnes TW (1994) Primary biliary cirrhosis: how should we evaluate new treatments? Lancet 343:1305-1306
16. Hansen MB, Nielsen SE, Berg K (1989) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210
17. Harris ED, Krane SM (1971) Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthritis Rheum 14:669-684
18. Homolka J, Mũller-Quernheim J (1993) Increased interleukin-6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung 171:173-180
19. Johnson MA, Kwan S, Snell NJC, Nunn AJ, Darbyshire JH, Turner-Warwick M (1989) Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 44:280-288
20. Kershenobich D, Vargas F, Garcia-Tsao G, Tamayo RP, Gent M, Rojkind M (1988) Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 318:1709-1713
21. Laurent GJ (1986) Lung collagen: more than scaffolding. Thorax 41:418-428
22. Levy M, Spino M, Read SE (1991) Colchicine: a state-of-the-art review. Pharmacotherapy 11:196-211
23. Mani S, Schmid-Alliana A, Kubar J, Ferrua B, Rossi B (1993) Disruption of microtubule network in human monocytes induces expression of interleukin-1 but not that of interleukin-6 nor tumor necrosis factor-α. J Biol Chem 268:13675-13681
24. Meier-Sydow J, Weiss SM, Buhl R, Rust M, Raghu G (1994) Idiopathic pulmonary fibrosis: current clinical concepts and challenges in management. Semin Respir Crit Care Med 15:77-96
25. Panos RJ, King TE (1991) Idiopathic pulmonary fibrosis. In: Lynch JP, DeRemee RA (eds) Immunologically mediated pulmonary diseases. Lippincott, Philadelphia, pp 1-39
26. Park J-H, Kim I-S, Park R-W, Jo J-S (1990) Inhibition of bleomycin-induced pulmonary fibrogenesis by colchicine. Korean J Biochem 22:39-46
27. Peters SG, McDougall JC, Douglas WW, Coles DT, DeRemee RA (1993) Colchicine in the treatment of pulmonary fibrosis. Chest 103:101-104
28. Poeschl A, Rehn D, Dumont JM, Müller PK, Hennings G (1987) Malotilate reduces collagen synthesis and cell migration activity of fibroblasts in vitro. Biochem Pharmacol 36:3957-3963
29. Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, Hutchinson J, Paradee NE, Winterbauer RH (1991) Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 144:291-296
30. Rennard SI, Bitterman PB, Ozaki T, Rom WN, Crystal RG (1988) Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. Am Rev Respir Dis 137:181-185
31. Sabouraud A, Rochdi M, Urtizberea M, Christen MO, Achtert G, Scherrmann JM (1992) Pharmacokinetics of colchicine: a review of experimental and clinical data. Z Gastroenterol 30(Suppl 1):35-39
32. Saito Y (1990) The effects of various drugs and immune complexes on the function of alveolar macrophages from patients with collagen-vascular diseases with interstitial pneumonia. Jpn J Arerugi 39:532-541
33. Schwartz DA, Helmers RA, Galvin JR, van Fossen DS, Frees KL, Dayton CS, Burmeister LF, Hunninghake GW (1994) Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149:450-454
34. Tiegs G, Freudenberg MA, Galanos C, Wendel A (1992) Colchicine prevents tumor necrosis factor-induced toxicity in vivo. Infect Immun 60:1941-1945
35. van Oortegem K, Wallaert B, Marquette CH, Ramon P, Perez T, Lafitte JJ, Tonnel AB (1994) Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis. Eur Respir J 7:1950-1957
36. Wangoo A, Haynes AR, Sutcliffe SP, Sorooshian M, Shaw RJ (1992) Modulation of platelet-derived growth factor B mRNA abundance in macrophages by colchicine and dibutyryl-cAMP. Mol Pharmacol 42:584-589
37. Weissler JC (1989) Southwestern internal medicine conference. Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis. Am J Med Sci 297:91-104
38. Wiestner M, Krieg T, Hörlein D, Glanville RW, Fietzek P, Müller PK (1979) Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures. J Biol Chem 254:7016-7023
39. Zhang L, Zhu Y, Luo W, Xi P, Yan Y (1992) The protective effect of colchicine on bleomycin-induced pulmonary fibrosis in rats. Chin Med Sci J 7:58-60